Redeye retains its positive view of Carasent following the Q4 report. Trading at 21.8x and 14.4x EBITDA-CAPEX 2026-2027e, the premium relative to other listed Nordic SaaS companies has increased, as many have seen much greater share price declines than Carasent. However, 15% organic growth is high for profitable SaaS companies, and we believe Carasent is among the most AI-resilient.
LÄS MER
